Study Examines QoL, Depression After CAR-T for Hematologic Malignancy

FRIDAY, April 7, 2023 -- For adults with hematologic malignancies receiving chimeric antigen receptor T-cell (CAR-T) therapy, quality of life (QoL) deteriorates and physical and psychological symptoms worsen one week after infusion and then improve...